Empire Financial Management Company, LLC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1971875
NEW YORK, NY
Position in VNDA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$6,372,712
-$3,402,008 QoQ
Shares Held
922,245
-16.8% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
1.86%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empire Financial Management Company, LLC holds $1,201,561 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,927 | $1,201,561 |
All Filings in VNDA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,372,712 | 922,245 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $9,774,720 | 1,108,245 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,782,874 | 758,091 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $920,400 | 195,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $688,500 | 150,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $306,560 | 64,000 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $267,150 | 65,000 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||